In this article recently published in the El Economista, David Uriarte explores how COVID-19 has encouraged medical and social experiments on sustainability, the economy, and the management of companies.
One of the ways in which human beings have managed to advance our knowledge and civilization is through experimentation. Experimenting means testing in order to explain or understand the nature of reality. Experimentation is one of the building blocks of innovation . Experimentation is based on changing the things we normally do .
Experimenting is often expensive and time consuming. It also forces us to get out of our comfort zone and seek new realities.
Covid-19 is posing a huge humanitarian challenge with, for now, more than 1.5 million deaths. In addition to its profound negative impact, it is generating new processes of innovation and digitization, because we are forced to experiment, we are forced to do many things differently.
All crises generate experiments, innovation and knowledge. World War II inoculated us against fascist ideology and advanced technology to hitherto unsuspected limits.
You just have to walk through the Royal Air Force Museum in London and see what airplanes were like before and after World War II to get an idea of this transformation.The sense of urgency and need to obtain a vaccine for Covid-19 has meant that a large amount of resources have been dedicated to its research and development. Thanks to this, new platforms based on RNA and DNA have been generated to obtain vaccines that may be used in the development of new vaccines in the future. With these technologies, vaccines can be developed more quickly because they do not require culture or fermentation and billions of people will benefit from them in the future.
Questions posed in this article include:
- What happens to pollution in a city
- What happens to an economy when millions of people cannot work
- How do organizations develop if their workers are related only digitally
Read the full article, COVID-19: The Great Experiment, on El Econimsta.es.
Umbrex is pleased to welcome Himanshu Sharma with Avolve Group. Himanshu has 15+ years of experience across strategy and operating roles across both in industry (Citi, Capital One) and consulting (4+ years at Monitor Deloitte Strategy), serving medium-large global clients. Himanshu has particular expertise in financial services and insurance, with a functional focus on strategy, new product solution development, partnerships and product marketing / go-to-market. He lives in Jersey City, NJ with his wife and daughter, performs stand-up comedy in his spare time and is patiently waiting for the New York comedy clubs to re-open.
Himanshu would love to collaborate on digital and business transformation growth projects.
Umbrex is pleased to welcome Christian Hager with Christian Hager Consulting. Christian Hager was a management advisor at McKinsey & Company from 2000 to 2010. In 2010 he started his own consulting practice. Christian focuses on growth topics, incl. strategy, business model development, sales initiatives, M&A, PMI, etc. and selectively supports restructuring and cost reduction projects. He serves clients in a broad range of industries, recently focusing on travel, logistics, insurance, and eCommerce. He lives in Zurich, Switzerland
Umbrex is pleased to welcome Jeff Boschwitz with JSB Consulting. Dr. Jeff Boschwitz has spent the last four years as an independent consultant focused on growth/new product and operations strategy for healthcare companies. Prior to that Jeff was COO of Personal Genome Diagnostics, EVP of Operations and Corporate Development at PLUS Diagnostics, VP Sales and Marketing for Orchid Cellmark and Director of Marketing Strategy and Analysis for Quest Diagnostics. Prior to going to industry, Jeff spent 10 years in consulting, the last five at Booz Allen Hamilton where he was a Principal in the healthcare practice.
Jeff received his PhD in Microbiology and Immunology from Cornell University and completed his Post-Doctoral work at Stanford University. He lives near Princeton NJ with his wife and spends his spare time with his racehorses. Jeff specializes in business unit, asset monetization, and cost reduction strategies and is happy to collaborate with anyone pursuing projects of this type for healthcare clients.
Umbrex is pleased to welcome Sean O’Toole with Forge. Sean O’Toole is a Partner at Forge > Outcomes, a growth innovation firm to F1000 companies. Sean specializes in deploying coaching leadership teams through change, building innovation capabilities, and launching new businesses.
A former McKinsey consultant, Sean has over 15 years P&L experience with American Express, Progressive Insurance, and Western Union. founded and sold a fintech company; and is an EIR
Sean is happy to collaborate and provide input on projects relating to innovation, growth, and strategic change.